1Stanojevic Z, Dordevic B, Zivanovic D. Influence of the primary malignant tumor site on the incidence and features of metastatic ovarian tumors. Vojnosanit Pregl,2007 ,64 :691- 696. 被引量：1
2Ho L, Quan V, Henderson R. Bilateral ovarian metastases from breast carcinoma on FDG PET-CT. Clin Nucl Med, 2007,32: 935 -936. 被引量：1
3Perrotin F, Marret H, Bouquin R, et al. Incidence, diagnosis and prognosis of ovarian metastasis in breast cancer. Gynecol Obstet Fertil,2001,29 :308-315. 被引量：1
4Tserkezoglou A, Kontou S, Hadjieleftheriou G, et al. Primary and metastatic ovarian cancer in patients with prior breast carcinoma; preoperative markers and treatment results. Anticancer Res, 2006,26:2339-2344. 被引量：1
5[1]Herold C I,Blackwell K L.The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormoneresponsive breast cancer.Breast,2008,17:S15-S24. 被引量：1
6[2]Doisneau Sixou S F,Serqio C M,Carroll J S,et al.Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.Endocr Relat Cancer,2003,10:179-186. 被引量：1
7[3]Waeber M,Castiqlione Gertsch M,Dietrich D,et al.Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence:definitive results of a phase Ⅲ randomized trial(SAKK23/82)comparing tamoxifen with observation.Ann Oncol,2003,14:1215-1221. 被引量：1
8[4]Fisher B,Dignam J,Bryant J,et al.Five versus more than five years of tamoxifen for lymph node-negative breast cancer:updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial.J Natl Cancer Inst,2001,93:684-90. 被引量：1
9[6]Mouridsen H,Gershanovich M.The role of aromatase inhibitors inthe treatment of metastatic breast cancer.Semin Oncol,2003,30:33-45. 被引量：1
10[7]Del Mastro L,Clavarezza M,Venturini M.Reducing the risk of distant metastases in breast cancer patients:role of aromatase inhibitors,2007,33:681-687. 被引量：1
2Hara F, Kiyoto S, Takabatake D, et al. Endometrial metastasis from breast cancer during adjuvant endocrine therapy [J]. Case Rep Oncol, 2010, 3(2) :137-141. 被引量：1
3Perez- Montiel D , Serrano-Olvera A, Salazar LC, et al.Adenocarcinoma metastatic to the uterine cervix: a case series [J]. I Obstet Gynaecol Res,2012,38(3) :541-549. 被引量：1
4D'souza MM, Sharma R, Tripathi M, et al.Cervical and uterine metastasis from carcinoma of breast diagnosed by PET/CT: an unusual presentation[J]. Clin Nucl Med, 2010 ,35 (10) :820-823. 被引量：1
5Isci H, Codoco N, Basqul A Y ,et al. Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment [J]. Eur I Cynaecol Oncol ,2011,32(5):560-562. 被引量：1
6Chikman B,Lavy R,Davidson T,et al.Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast[J].Isr Med Assoc,2010,1201):697-700. 被引量：1
7Richter G,Uleer C,Noesselt T.Multifocal invasive ductal breast cancer with osteoclast-like giant cells:a case report[J].J Med Case Reports,2011,27(5):85. 被引量：1
8Brogi E,Murray MP,Corben AD.Lobular Carcinoma,Not Only a Classic[J].The breast Journal,2010,16:2010,S10-S14. 被引量：1
9Papaioannou N,Zervoudis S,Grammatikakis I,et al.Metastatic lobular carcinoma of the breast to the vulva:a case report and review of the literature[J].J Egypt Natl Canc Inst,2010,22(1):57-60. 被引量：1
